FDA Enforcement Class II Ongoing

EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in human serum. This kit is to be used as an aid for the detection of novel COVID-19. Patients with suspected clustering cases require diagnosis or differential diagnosis of novel coronavirus infection.

Recall: Z-0426-2021 · Reported November 18, 2020

Enforcement

Recall Number
Z-0426-2021
Event ID
86516
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Epitope Diagnostics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
November 18, 2020
Initiation Date
October 1, 2020
Classification Date
November 6, 2020
Address
7110 Carroll Rd, San Diego, CA, 92121-2215, United States

Description

EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in human serum. This kit is to be used as an aid for the detection of novel COVID-19. Patients with suspected clustering cases require diagnosis or differential diagnosis of novel coronavirus infection.

Reason

The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value.

Code Info

Lot Numbers: P826, P815, P796, P776

Distribution

U.S Distribution.: NH, CO, OR, CA, FL, NY, MD, NJ, IL, NC, MI, TX, PA, MA, OH, NM, VA, SC, HI, and TN.

Quantity

2886